Regulation of transduction efficiency by pegylation of baculovirus vector in vitro and in vivo

Journal of Biotechnology

Volumn 125, Issue 1, 2006, Pages 104-109

  Kim, You Kyoung ^a   Park, In Kyu ^a   Jiang, Hu Lin ^a   Choi, Jae Young ^a   Je, Yeon Ho ^a   Jin, Hua ^a   Kim, Hyun Woo ^a   Cho, Myung Haing ^a   Cho, Chong Su ^a  

^a Seoul National University   (South Korea)

Author keywords

Baculovirus; Green fluorescent protein (GFP); Pegylation; Transduction efficiency

Indexed keywords

AMINES; ASSAYS; FLUORESCENCE; PROTEINS;

BACULOVIRUS; GREEN FLUORESCENT PROTEIN (GFP); PEGYLATION; TRANSDUCTION EFFICIENCY;

POLYETHYLENE GLYCOLS;

AMINE; FLUORESCAMINE; GREEN FLUORESCENT PROTEIN; MACROGOL; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; BIOASSAY; BRAIN; CONTROLLED STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; VIRION;

ANIMALS; BACULOVIRIDAE; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; POLYETHYLENE GLYCOLS; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 33746021121     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2006.02.015     Document Type: Article

References (25)

1. Abuchowski A., Kazo G.M., Verhoest Jr. C.R., Van Es.T., Kafkewitz D., Nucci M.L., Viau A.T., and Davis F.F. Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys. 7 (1984) 175-186
2. Boyce F.M., and Bucher N.L.R. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2348-2352
3. Brunner S., Sauer T., Carotta S., Cotten M., Saltik M., and Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 7 (2000) 401-407
4. Cavazzana-Calvo M., Thrasher A., and Mavilio F. The future of gene therapy. Nature 427 (2004) 779-781
5. Croyle M.A., Chirmule N., Zhang Y., and Wilson J.M. Stealth adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75 (2001) 4792-4801
6. Croyle M.A., Yu Q.C., and Wilson J.M. Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Hum. Gene Ther. 11 (2000) 1713-1722
7. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success. Science 270 (1995) 404-410
8. 2a and its individual positional isomers. Bioconjug. Chem. 16 (2005) 504-517
9. Duisit G., Saleun S., Douthe S., Barsoum J., Chadeuf G., and Moullier P. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J. Gene Med. 1 (1999) 93-102
10. Hofmann C., and Strauss M. Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 5 (1998) 531-536
11. + virus production. Int. J. Ind. Entomol. (2001) 155-160
12. Jozkowicz A., and Dulak J. Helper-dependent adenoviral vectors in experimental gene therapy. Acta Biochim. Pol. 52 (2005) 589-599
13. Katakura H., Harada A., Kataoka K., Furusho M., Tanaka F., Wada H., and Ikenaka K. Improvement of retroviral vectors by coating with poly(ethylene glycol)-poly(l-lysine) block copolymer (PEG-PLL). J. Gene Med. 6 (2004) 471-477
14. Kost T.A., and Condreay J.P. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotech. 20 (2002) 173-180
15. Mahato R.I., Smith L.C., and Rolland A. Pharmaceutical perspectives of nonviral gene therapy. Adv. Genet. 41 (1999) 95-156
16. Mok H., Palmer D.J., Ng P., and Barry M.A. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenovirus vectors to reduce innate immune responses. Mol. Ther. 11 (2005) 66-79
17. O'Riordan C.R., Lachapelle A., Delgado C., Parkes V., Wadsworth S.C., Smith A.E., and Francis G.E. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum. Gene Ther. 10 (1999) 1349-1358
18. Pennock G.D., Shoemaker C., and Miller L.K. Strong and regulated expression of Escherichia coli beta-galactosidase in insect cells with a baculovirus vector. Mol. Cell Biol. 4 (1984) 399-406
19. Ross P.C., and Hui S.W. Polyethylene glycol enhances lipoplex-cell associated and lipofection. Biochim. Biophys. Acta 1421 (1999) 273-283
20. Sandig V., Hoffmann C., Steinert S., Jennings G., Schlag P., and Strauss M. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7 (1996) 1937-1945
21. Sarkis C., Serguera C., Petres S., Buchet D., Ridet J.-L., Edelman L., and Mallet J. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 14638-14643
22. Tang T.C., Johnston S.A., and Carbone D.P. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Cancer Gene Ther. 1 (1994) 15-20
23. Tani H., Limn C.K., Yap C.C., Onishi M., Nozaki M., Nishimune Y., Okahashi N., Kitagawa Y., Watanabe R., Mochizuki R., Moriishi K., and Matsuura Y. In vitro and in vivo gene delivery by recombinant baculoviruses. J. Virol. 77 (2003) 9799-9808
24. Tripathy S.K., Black H.B., Goldwasser E., and Leiden J.M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2 (1996) 545-550
25. Weiss R.A., and Tailor C.S. Retrovirus receptors. Cell 82 (1995) 531-533